Humanigen, Inc. (OTCQB: HGEN) CEO Interview Podcast
THIS INTERVIEW HAS EXPIRED
THIS INTERVIEW HAS EXPIRED
About: Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. We have two areas of focus: 1) a specialized biotherapeutics segment dedicated […]
THIS INTERVIEW HAS EXPIRED
Click here for corporate deck INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street, this is Juan Costello, Senior analyst with the Wall Street Analyzer. Joining us today is Michael Jennings CEO for Next Green Wave […]
Interview with COO Bill Abajian […]
Interview update with CEO Miriam Tuerk […]
About: NaturalShrimp, Inc. (OTCQB: SHMP) a publicly traded agro-tech company, has developed patented proprietary technology to produce fresh, gourmet-grade shrimp without the use of antibiotics, probiotics or toxic chemicals. NaturalShrimp systems are self-contained, saltwater production […]
THIS INTERVIEW HAS EXPIRED
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com